Correlation Between Lyra Therapeutics and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and Inozyme Pharma, you can compare the effects of market volatilities on Lyra Therapeutics and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Inozyme Pharma.
Diversification Opportunities for Lyra Therapeutics and Inozyme Pharma
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Lyra and Inozyme is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Inozyme Pharma go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and Inozyme Pharma
Given the investment horizon of 90 days Lyra Therapeutics is expected to generate 2.32 times more return on investment than Inozyme Pharma. However, Lyra Therapeutics is 2.32 times more volatile than Inozyme Pharma. It trades about -0.1 of its potential returns per unit of risk. Inozyme Pharma is currently generating about -0.73 per unit of risk. If you would invest 25.00 in Lyra Therapeutics on August 28, 2024 and sell it today you would lose (6.00) from holding Lyra Therapeutics or give up 24.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyra Therapeutics vs. Inozyme Pharma
Performance |
| Timeline |
| Lyra Therapeutics |
| Inozyme Pharma |
Lyra Therapeutics and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and Inozyme Pharma
The main advantage of trading using opposite Lyra Therapeutics and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| Lyra Therapeutics vs. Eliem Therapeutics | Lyra Therapeutics vs. HCW Biologics | Lyra Therapeutics vs. Scpharmaceuticals | Lyra Therapeutics vs. Milestone Pharmaceuticals |
| Inozyme Pharma vs. Eliem Therapeutics | Inozyme Pharma vs. HCW Biologics | Inozyme Pharma vs. Scpharmaceuticals | Inozyme Pharma vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |